Aditxt (ADTX) Equity Average (2019 - 2026)
Aditxt (ADTX) recorded quarterly Equity Average of -$14.8 million in Q1 2026, down 1292.57% quarter-over-quarter from -$1.1 million in Q4 2025, and down 262.36% on a YoY basis from $9.1 million in Q1 2025.
Aditxt (ADTX) Equity Average (2019 - 2026) Analysis & Trends
Aditxt's Equity Average history runs 8 years deep, the most recent figure standing at -$14.8 million for Q1 2026.
- In Q1 2026, Equity Average fell 262.36% year-over-year to -$14.8 million; the TTM figure through Mar 2026 stood at -$14.8 million (down 262.36% YoY), while the FY2025 annual figure was $3.4 million, down 60.9% from the prior year.
- Equity Average was -$14.8 million for Q1 2026 at Aditxt, down from -$1.1 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $15.2 million in Q2 2025 to a low of -$14.8 million in Q1 2026.
- Historically, Equity Average has averaged $4.1 million across 5 years, with a median of $5.4 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Equity Average surged 524.21% in 2024, then sank 262.36% in 2026.
- A 5-year view of Equity Average shows it stood at $9.0 million in 2022, then plunged by 33.94% to $5.9 million in 2023, then sank by 53.15% to $2.8 million in 2024, then sank by 138.32% to -$1.1 million in 2025, then tumbled by 1292.57% to -$14.8 million in 2026.
- The last three Equity Average figures came in at -$14.8 million (Q1 2026), -$1.1 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | -14.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.78 Mn |
| Dec 31, 2025 | -1.06 Mn |
| Sep 30, 2025 | 2.81 Mn |
| Jun 30, 2025 | 15.23 Mn |
| Mar 31, 2025 | 9.10 Mn |
| Dec 31, 2024 | 2.77 Mn |
| Sep 30, 2024 | 5.40 Mn |
| Jun 30, 2024 | 8.06 Mn |
| Mar 31, 2024 | 12.91 Mn |
| Dec 31, 2023 | 5.91 Mn |
| Sep 30, 2023 | -4.05 Mn |
| Jun 30, 2023 | -1.90 Mn |
| Mar 31, 2023 | 2.64 Mn |
| Dec 31, 2022 | 8.95 Mn |
| Sep 30, 2022 | 7.03 Mn |
| Jun 30, 2022 | 3.04 Mn |
| Mar 31, 2022 | 7.45 Mn |
| Dec 31, 2021 | 11.58 Mn |
| Sep 30, 2021 | 9.47 Mn |
| Jun 30, 2021 | 8.67 Mn |